GlassScriptPhysician profile
Yefim Cavalier
NPI 1023308327
$1,243.99
in general payments reported to CMS, 2019-2025
24 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Sleep Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $337).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $113 · 2022: $528 · 2023: $251 · 2024: $59.03 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $137.21 | 2022-2023 | Wakix |
| Pfizer INC. | $131.85 | 2022-2024 | |
| Jazz Pharmaceuticals INC. | $125.18 | 2019 | |
| Abbvie INC. | $119.77 | 2022-2023 | Botox, Qulipta |
| Inspire Medical Systems, INC. | $113.28 | 2020 | |
| Livanova USA, INC. | $106.05 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Ucb, INC. | $91.11 | 2022 | |
| Genentech USA, INC. | $53.83 | 2022 | |
| Amgen INC. | $38.90 | 2019-2022 | |
| Philips North America LLC | $38.00 | 2019 | |
| Mdd US Operations, LLC | $28.19 | 2022 | |
| Lundbeck LLC | $27.40 | 2022 | |
| Janssen Pharmaceuticals, INC | $25.66 | 2022 | |
| Lilly USA, LLC | $23.96 | 2022 | |
| Averitas Pharma INC. | $23.51 | 2023 | Qutenza |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $20.98 | 2022 | |
| Alexion Pharmaceuticals, INC. | $20.87 | 2022 | |
| Boston Scientific Corporation | $19.98 | 2023 | |
| Emd Serono, INC. | $18.85 | 2022 | |
| Fisher & Paykel Healthcare INC | $18.27 | 2024 | Fisher & Paykel Healthcare |
| Amneal Pharmaceuticals LLC | $18.01 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $17.28 | 2022 | |
| Tanabe Pharma America, INC. | $12.95 | 2022 | |
| Ani Pharmaceuticals, INC. | $12.90 | 2023 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yefim Cavalier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.